$148 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 66.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $12,046,545 | +64.5% | 31,500 | +53.7% | 8.14% | +72.1% |
BAC | Buy | BK OF AMERICA CORP | $7,948,800 | +75.5% | 240,000 | +60.0% | 5.37% | +83.5% |
GOOG | Buy | ALPHABET INCcap stk cl c | $7,275,860 | -5.4% | 82,000 | +2.5% | 4.92% | -1.1% |
PRTA | Buy | PROTHENA CORP PLC | $4,464,525 | +8.3% | 74,100 | +9.0% | 3.02% | +13.3% |
ET | Buy | ENERGY TRANSFER L P | $4,362,225 | +9.9% | 367,500 | +2.1% | 2.95% | +14.9% |
GLD | Buy | SPDR GOLD TR | $4,071,360 | +17.0% | 24,000 | +6.7% | 2.75% | +22.4% |
ORCL | Buy | ORACLE CORP | $3,514,820 | +47.6% | 43,000 | +10.3% | 2.38% | +54.3% |
ALT | Buy | ALTIMMUNE INCcall | $2,451,050 | +754.0% | 149,000 | +562.2% | 1.66% | +795.1% |
VOO | New | VANGUARD INDEX FDSput | $1,756,700 | – | 5,000 | +100.0% | 1.19% | – |
GDXJ | New | VANECK ETF TRUSTjunior gold mine | $1,604,250 | – | 45,000 | +100.0% | 1.08% | – |
SGEN | Buy | SEAGEN INC | $1,599,950 | -0.5% | 12,450 | +6.0% | 1.08% | +4.0% |
JQC | Buy | NUVEEN CR STRATEGIES INCOME | $1,585,128 | +97.6% | 311,420 | +98.4% | 1.07% | +106.8% |
SLV | Buy | ISHARES SILVER TRishares | $1,310,190 | +49.7% | 59,500 | +19.0% | 0.88% | +56.6% |
SHY | New | ISHARES TRput | $933,455 | – | 11,500 | +100.0% | 0.63% | – |
SNY | Buy | SANOFIsponsored adr | $702,235 | +67.6% | 14,500 | +31.7% | 0.48% | +75.3% |
VIR | New | VIR BIOTECHNOLOGY INC | $607,440 | – | 24,000 | +100.0% | 0.41% | – |
BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $572,585 | – | 6,500 | +100.0% | 0.39% | – |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDcall | $558,675 | +62.9% | 7,500 | +50.0% | 0.38% | +70.3% |
PAAS | New | PAN AMERN SILVER CORP | $531,050 | – | 32,500 | +100.0% | 0.36% | – |
GOLD | Buy | BARRICK GOLD CORP | $515,400 | +232.5% | 30,000 | +200.0% | 0.35% | +248.0% |
New | TURNING PT BRANDS INC2.500% 7/1 | $439,485 | – | 500,000 | +100.0% | 0.30% | – | |
BUR | Buy | BURFORD CAP LTDcall | $370,010 | +26.3% | 45,400 | +16.4% | 0.25% | +32.3% |
XBI | New | SPDR SER TRs&p biotech | $290,500 | – | 3,500 | +100.0% | 0.20% | – |
BUR | Buy | BURFORD CAP LTD | $285,250 | +46.3% | 35,000 | +34.6% | 0.19% | +53.2% |
TGNA | New | TEGNA INC | $264,875 | – | 12,500 | +100.0% | 0.18% | – |
EQ | Buy | EQUILLIUM INC | $262,416 | -49.4% | 247,562 | +5.9% | 0.18% | -47.2% |
XLE | New | SELECT SECTOR SPDR TRput | $218,675 | – | 2,500 | +100.0% | 0.15% | – |
Buy | ESPERION THERAPEUTICS INC NEnote 4.000%11/1 | $198,900 | -77.5% | 3,600,000 | +132.3% | 0.13% | -76.5% | |
PAAS | New | PAN AMERN SILVER CORPcall | $163,400 | – | 10,000 | +100.0% | 0.11% | – |
AMRN | New | AMARIN CORP PLCspons adr new | $24,200 | – | 20,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
ALPHABET INC | 16 | Q3 2023 | 5.8% |
ABBVIE INC | 16 | Q3 2023 | 7.9% |
REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
ARGENX SE | 16 | Q3 2023 | 6.4% |
SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
XENCOR INC | 16 | Q3 2023 | 4.1% |
BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-10 |
13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.